Ligand Pharmaceuticals Incorporated (LGND) — Net Asset Momentum
Ligand Pharmaceuticals Incorporated (LGND) recorded a net asset momentum of 22.5% as of December 2025, with net assets of $1.02 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See LGND net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Ligand Pharmaceuticals Incorporated Net Asset Momentum (1994–2025)
This chart tracks Ligand Pharmaceuticals Incorporated's year-over-year net asset growth across 32 annual reporting periods from 1994 to 2025. The most recent momentum reading is +22.5%, with net assets of $1.02 Billion USD as of December 2025. For live market cap and overall valuation, see Ligand Pharmaceuticals Incorporated market capitalisation.
Annual Net Asset History for Ligand Pharmaceuticals Incorporated (1994–2025)
The table below shows the complete annual net asset history for Ligand Pharmaceuticals Incorporated from 1994 to 2025, covering 32 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Ligand Pharmaceuticals Incorporated (LGND) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $1.02 Billion | $1.56 Billion | $543.42 Million | ▲ +22.5% |
| 2024 | $830.44 Million | $941.77 Million | $111.33 Million | ▲ +18.5% |
| 2023 | $700.91 Million | $787.22 Million | $86.30 Million | ▲ +17.3% |
| 2022 | $597.49 Million | $762.67 Million | $165.18 Million | ▼ -27.2% |
| 2021 | $821.16 Million | $1.30 Billion | $476.43 Million | ▲ +15.7% |
| 2020 | $709.52 Million | $1.36 Billion | $652.76 Million | ▼ -7.5% |
| 2019 | $767.23 Million | $1.49 Billion | $727.68 Million | ▲ +36.8% |
| 2018 | $560.91 Million | $1.26 Billion | $699.89 Million | ▲ +34.0% |
| 2017 | $418.65 Million | $671.02 Million | $252.37 Million | ▲ +12.9% |
| 2016 | $370.85 Million | $601.59 Million | $230.73 Million | ▲ +21.8% |
| 2015 | $304.39 Million | $533.93 Million | $229.54 Million | ▲ +1147.1% |
| 2014 | $24.41 Million | $258.03 Million | $233.62 Million | ▼ -50.8% |
| 2013 | $49.61 Million | $104.71 Million | $55.10 Million | ▲ +87.3% |
| 2012 | $26.48 Million | $104.26 Million | $77.78 Million | ▲ +206.3% |
| 2011 | $8.65 Million | $122.35 Million | $113.70 Million | ▲ +223.7% |
| 2010 | $-6.99 Million | $75.56 Million | $82.55 Million | ▼ -286.7% |
| 2009 | $3.74 Million | $113.70 Million | $109.95 Million | ▲ +136.1% |
| 2008 | $-10.37 Million | $171.45 Million | $181.81 Million | ▼ -135.6% |
| 2007 | $29.11 Million | $173.28 Million | $144.16 Million | ▲ +6.4% |
| 2006 | $27.35 Million | $326.05 Million | $298.70 Million | ▲ +124.8% |
| 2005 | $-110.42 Million | $314.62 Million | $425.04 Million | ▼ -46.6% |
| 2004 | $-75.32 Million | $332.47 Million | $407.78 Million | ▼ -206.5% |
| 2003 | $70.73 Million | $301.25 Million | $230.53 Million | ▼ -4.4% |
| 2002 | $74.02 Million | $270.61 Million | $196.59 Million | ▲ +227.9% |
| 2001 | $-57.88 Million | $117.47 Million | $175.35 Million | ▼ -5.0% |
| 2000 | $-55.12 Million | $113.42 Million | $168.55 Million | ▼ -115.3% |
| 1999 | $-25.60 Million | $134.60 Million | $160.20 Million | ▼ -124.6% |
| 1998 | $-11.40 Million | $156.00 Million | $167.40 Million | ▼ -133.2% |
| 1997 | $34.30 Million | $107.40 Million | $73.10 Million | ▼ -0.6% |
| 1996 | $34.50 Million | $102.10 Million | $67.60 Million | ▲ +22.8% |
| 1995 | $28.10 Million | $93.60 Million | $65.50 Million | ▲ +6.8% |
| 1994 | $26.30 Million | $46.70 Million | $20.40 Million | — |